Xencor
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Xencor and other ETFs, options, and stocks.About XNCR
Xencor, Inc. is a biopharmaceutical company, which engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. Its proprietary technology platform, XmAb, is used to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer, and other conditions.
CEOBassil I. Dahiyat
CEOBassil I. Dahiyat
Employees250
Employees250
HeadquartersPasadena, California
HeadquartersPasadena, California
Founded1997
Founded1997
Employees250
Employees250
XNCR Key Statistics
Market cap1.05B
Market cap1.05B
Price-Earnings ratio-6.11
Price-Earnings ratio-6.11
Dividend yield—
Dividend yield—
Average volume1.56M
Average volume1.56M
High today$15.25
High today$15.25
Low today$14.47
Low today$14.47
Open price$14.85
Open price$14.85
Volume1.94M
Volume1.94M
52 Week high$27.24
52 Week high$27.24
52 Week low$6.92
52 Week low$6.92
XNCR News
Simply Wall St 10h
A Look at Xencor's Valuation After 60% Rally This MonthXencor (XNCR) shares have moved nearly 60% higher over the past month, catching the attention of investors interested in biotechnology stocks with a turnaround...
TipRanks 5d
Xencor price target raised to $14 from $12 at BofABofA raised the firm’s price target on Xencor (XNCR) to $14 from $12 and keeps a Neutral rating on the shares. Initial data for XmAb819, Xencor’s T-cell engager...
Analyst ratings
85%
of 13 ratingsBuy
84.6%
Hold
7.7%
Sell
7.7%
People also own
Based on the portfolios of people who own XNCR. This list is generated using Robinhood data, and it’s not a recommendation.